Cephalon, Inc. was a U.S. biopharmaceutical company co-founded in 1987 by Dr. Frank Baldino, Jr., pharmacologist, Dr. Michael Lewis] neuroscientist and Dr. James C. Kauer] organic chemist, all three former scientists with the DuPont Company. Dr. Baldino served as the company's chairman and chief executive officer until his death in December 2010. The company's name comes from the adjective "cephalic" meaning "related to the head or brain," and it was established primarily to pursue treatments for neurodegenerative diseases.

Cephalon, Inc. was a U.S. biopharmaceutical company co-founded in 1987 by Dr. Frank Baldino, Jr., pharmacologist, Dr. Michael Lewis] neuroscientist and Dr. James C. Kauer] organic chemist, all three former scientists with the DuPont Company. Dr. Baldino served as the company's chairman and chief executive officer until his death in December 2010. The company's name comes from the adjective "cephalic" meaning "related to the head or brain," and it was established primarily to pursue treatments for neurodegenerative diseases.